Met Life Investment Management, LLC Oramed Pharmaceuticals Inc. Transaction History

Met Life Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.72 - $9.0 $64,579 - $156,240	-17,360 Closed	0 $0
Q1 2022 May 10, 2024	BUY	$8.19 - $13.89 $142,178 - $241,130	17,360 New	17,360 $150,000
Q1 2022 Jun 20, 2023	BUY	$8.19 - $13.89 $142,178 - $241,130	17,360 New	17,360 $150,000
Q1 2022 Mar 22, 2023	BUY	$8.19 - $13.89 $52,473 - $88,993	6,407 Added 58.5%	17,360 $150,000
Q1 2022 May 12, 2022	BUY	$8.19 - $13.89 $52,473 - $88,993	6,407 Added 58.5%	17,360 $150,000
Q4 2021 Jun 21, 2023	BUY	$12.98 - $29.75 $142,169 - $325,851	10,953 New	10,953 $156,000
Q3 2021 Jun 21, 2023	BUY	$12.13 - $23.82 $132,859 - $260,900	10,953 New	10,953 $240,000
Q2 2021 May 17, 2024	BUY	$8.34 - $14.59 $91,348 - $159,804	10,953 New	10,953 $146,000
Q2 2021 Jun 21, 2023	BUY	$8.34 - $14.59 $91,348 - $159,804	10,953 New	10,953 $146,000
Q2 2021 Mar 22, 2023	BUY	$8.34 - $14.59 $91,348 - $159,804	10,953 New	10,953 $146,000
Q2 2021 Aug 16, 2021	BUY	$8.34 - $14.59 $91,348 - $159,804	10,953 New	10,953 $147,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.